MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,191K
Free Cash flow
-$7,367K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of notes ...
Accounts payable and accrued exp...
Prepaid expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Change in fair value of converti...
Payment to related party
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-9,221
-3,069
1,388
-26,829
Depreciation and amortization
774
771
728
451
Amortization of debt discount
125
277
614
414
Change in fair value of derivatives
0
9,416
1,177
-3,332
Change in fair value of share payable
64
201
-33
-118
Change in fair value of convertible notes
6,432
5,235
19,559
-15
Loss from extinguishment of debt
-2,180
-4,756
-1,595
-4,004
Loss from issuance of debt
0
-738
-2,292
-1,611
Inducement expense
0
87
-
-
Non - cash financing cost
-150
-
-
-
Amortization of operating lease right-of-use asset
78
76
73
70
Stock-based compensation for services
181
288
185
273
Allowance for credit loss
14
311
-
-
Subtotal of non-cash charges
-2,994
-7,548
-15,216
10,288
Prepaid expenses and other current assets
-2,430
2,276
448
500
Other non-current assets
0
-2
-2
-10
Accounts payable and accrued expenses
2,722
886
-1,103
1,321
Related party accounts payable and accrued expenses
0
-364
551
1,825
Lease liabilities
-106
-140
62
-8
Net cash used in operating activities
-7,169
-12,509
-14,764
-13,893
Purchase of equipment and construction in progress
198
129
905
202
Loan receivable
-
-
0
311
Net cash used in investing activities
-198
-129
-905
-513
Proceeds from issuance of common shares
104
2,900
2,015
4,862
Proceeds from exercise of warrants
14
6
0
0
Proceeds from issuance of notes payable, net
7,000
-
5,000
0
Proceeds from issuance of convertible notes payable, net
925
7,469
6,573
7,175
Repayment of notes payable
-
-
0
4
Proceeds from warrant modification
2
-
-
-
Repayment of convertible notes payable
0
500
0
475
Payment of purchase consideration to related party
-
666
-
-
Payment to related party
1,339
-
-
-
Net cash provided by financing activities
7,372
9,209
13,588
11,558
Effect of exchange rate changes on cash and cash equivalents
-1,196
2,175
561
3,092
Net (decrease) increase in cash and cash equivalents
-1,191
-1,254
-1,520
244
Cash and cash equivalents, beginning of the period
1,786
3,040
4,560
2,175
Cash and cash equivalents, end of the period
595
1,786
3,040
4,560
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
notes payable, net
$7,000K
(0.00%↑ Y/Y)
Proceeds from issuance of
convertible notes payable,...
$925K
(-83.20%↓ Y/Y)
something is missing
$666K
Proceeds from issuance of
common shares
$104K
(-99.16%↓ Y/Y)
Proceeds from exercise of
warrants
$14K
(-39.13%↓ Y/Y)
Proceeds from warrant
modification
$2K
Net cash provided by
financing activities
$7,372K
(-69.51%↓ Y/Y)
Canceled cashflow
$1,339K
Net (decrease)
increase in cash and cash...
-$1,191K
(-155.63%↓ Y/Y)
Canceled cashflow
$7,372K
Accounts payable and
accrued expenses
$2,722K
(-63.87%↓ Y/Y)
Prepaid expenses and
other current assets
-$2,430K
(-2089.19%↓ Y/Y)
Payment to related party
$1,339K
Net cash used in
operating activities
-$7,169K
(55.49%↑ Y/Y)
Canceled cashflow
$5,152K
Effect of exchange rate
changes on cash and cash...
-$1,196K
(78.40%↑ Y/Y)
Net cash used in
investing activities
-$198K
(50.13%↑ Y/Y)
Loss from
extinguishment of debt
-$2,180K
(81.52%↑ Y/Y)
Depreciation and
amortization
$774K
(-12.54%↓ Y/Y)
Stock-based compensation
for services
$181K
(-75.83%↓ Y/Y)
Non - cash financing
cost
-$150K
Amortization of debt discount
$125K
(-85.45%↓ Y/Y)
Amortization of operating
lease right-of-use...
$78K
(-40.00%↓ Y/Y)
Allowance for credit loss
$14K
Net loss
-$9,221K
(73.44%↑ Y/Y)
Subtotal of non-cash
charges
-$2,994K
(-140.66%↓ Y/Y)
Lease liabilities
-$106K
(-371.79%↓ Y/Y)
Purchase of equipment and
construction in progress
$198K
(-50.13%↓ Y/Y)
Canceled cashflow
$3,502K
Change in fair value of
convertible notes
$6,432K
(5.63%↑ Y/Y)
Change in fair value of
share payable
$64K
(124.33%↑ Y/Y)
Buy us a coffee
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
NORTHWEST BIOTHERAPEUTICS INC (NWBO)